The Current Ratio as of December 2025 (TTM) for AmCad BioMed Corporation (4188.TWO) is 24.52

According to AmCad BioMed Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 24.52. This represents a change of 13.78% compared to the average of 21.55 of the last 4 quarters.

AmCad BioMed Corporation (4188.TWO) Historical Current Ratio (quarterly & annually)

How has 4188.TWO Current Ratio performed in the past?

The mean historical Current Ratio of AmCad BioMed Corporation over the last ten years is 11.22. The current 24.52 Current Ratio has changed 21.76% with respect to the historical average. Over the past ten years (40 quarters), 4188.TWO's Current Ratio was at its highest in in the June 2025 quarter at 24.52. The Current Ratio was at its lowest in in the December 2022 quarter at 13.15.

AmCad BioMed Corporation (4188.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AmCad BioMed Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AmCad BioMed Corporation (4188.TWO) Average Current Ratio

How has 4188.TWO Current Ratio performed in the past?

The current Current Ratio of AmCad BioMed Corporation (4188.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AmCad BioMed Corporation (4188.TWO) Current Ratio vs. Peers

How is 4188.TWO’s Current Ratio compared to its peers?

AmCad BioMed Corporation’s Current Ratio is greater than PlexBio Co., Ltd. (2.88), greater than TFBS Bioscience Inc. (2.43), greater than Puriblood Medical Co., Ltd. (2.81), greater than SynCore Biotechnology Co.,Ltd (11.18), greater than NatureWise Biotech & Medicals Corporation (11.89), greater than Radiant Innovation Inc. (11.22), less than Eusol Biotech Co.,Ltd. (43.56), greater than Andros Pharmaceuticals Co.,Ltd (13.81), greater than LAUNXP Biomedical Co., Ltd (7.53), greater than General Biologicals Corporation (1.32),

Build a custom stock screener for AmCad BioMed Corporation (4188.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AmCad BioMed Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AmCad BioMed Corporation (4188.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AmCad BioMed Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.